Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients

Clinical trial NCT05062889 · SUSPENDED

Trial details

NCT number: NCT05062889
Sponsor: Gruppo Oncologico del Nord-Ovest
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage II Colon Cancer Stage III Colon Cancer HER2-positive Colon Cancer RAS Wild-type Colon Cancer

Start date: 2023-05-17
Primary completion: 2027-10-01
Enrollment: 477

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.